Home
|
Inbox
|
Search
|
Speaker
Lisa Hood. Lancaster
M.D.
Vanderbilt Univ Medical Ctr;Vanderbilt University;Vanderbilt University Medical Center
Session(s)
- Nintedanib and Pirfenidone as a Bridge to Lung Transplant in Idiopathic Pulmonary Fibrosis...
Sunday, May 20 11:15 AM - 1:00 PM - Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF)...
Sunday, May 20 11:15 AM - 1:00 PM - Clinical Features and Outcomes Associated with Telomere Pathway Mutations in Familial Inte...
Sunday, May 20 2:15 PM - 4:15 PM - Moderator
Sunday, May 20 2:15 PM - 4:15 PM - Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (...
Monday, May 21 2:15 PM - 4:15 PM - Outcomes of Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Patients with Ci...
Monday, May 21 2:15 PM - 4:15 PM - Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose-Escalation Study of BG00...
Wednesday, May 23 9:15 AM - 9:30 AM - The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial ...
Wednesday, May 23 10:45 AM - 11:00 AM
|
Home
|
Inbox
|
Search
|